Novartis' R&D expenditure as a percent of revenue 2004-2023

Novartis AG's R&D expenditure as a percent of revenue from 2004 to 2023

Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

January 2024

Region

Worldwide

Survey time period

2004 to 2023

Supplementary notes

This statistic was assembled from several editions of Novartis' annual report.
* With the 2015 Annual Report, values back to 2011 were restated, as a result of a series of transactions during 2015.
** Calculated based on given figures.
*** Calculated based on given figures. During this year, eye care division Alcon was spun off and became an own company. Thus, Alcon's revenues and expenses are not included from this year onwards.
**** Calculated based on given figures. During this year, generics division Sandoz was spun off and became an own company, leading to a higher R&D percentage.

Open this statistic in...
Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Novartis "

Other statistics that may interest you Novartis

Overview

6

Financials

5

Segments

4

Competitors

6

Research and development

4

Outlook

4

Further related statistics

16
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.